Results 211 to 220 of about 4,673,795 (354)
ABSTRACT Ritlecitinib is an oral JAK3/TEC family kinase inhibitor approved for individuals aged ≥ 12 years with severe alopecia areata. Here we report interim efficacy and safety results with ritlecitinib up to Month 24 in the Asian subpopulation from the ALLEGRO phase 2b/3 and ALLEGRO‐LT studies.
Rie Ueki +13 more
wiley +1 more source
Epstein-Barr Virus Load in the Saliva of Patients with Oropharyngeal Cancer-Could It Have Prognostic Significance? [PDF]
Paradowski K +4 more
europepmc +1 more source
ABSTRACT Aim This technical report describes our experience with eight patients with small lung lesions (less than 2 cm) treated by thermal ablation after rapid on‐site cytological confirmation of cancer diagnosis. Materials and Methods Six patients were treated by microwave ablation and two by cryoablation, under local anaesthesia.
Andrei B. Gorgos +4 more
wiley +1 more source
Postoperative swallowing recovery in oral and oropharyngeal cancer: A prospective analysis of functional changes and adjuvant therapy effects. [PDF]
Nguyen LTH, Vo DT, Thai TT, Ly XQ.
europepmc +1 more source
ABSTRACT Head and neck radiotherapy (HNRT) can expose teeth to moderate radiation doses, yet the effects on root dentine under clinically relevant conditions remain unclear. This in vitro study compared dentine subjected to 0, 30, or 50 Gy IMRT. Palatal roots from 35 maxillary molars were allocated to non‐irradiated, 30 Gy (oropharyngeal simulation ...
Anna Victória Costa Serique +11 more
wiley +1 more source
Endoscopic replacement of a transgastric feeding tube in advanced oropharyngeal cancer with esophageal obstruction using transgastrostomy endoscopy. [PDF]
Alwali A +3 more
europepmc +1 more source
ABSTRACT Background Monitoring delivery of cancer care is critical to improve outcomes in increasingly resource‐constrained settings. The aim of this study was to develop a priority set of multidisciplinary quality indicators (QIs) for benchmarking and monitoring the quality of care for head and neck cancer (HNC) in Australia.
Rebecca L. Venchiarutti +17 more
wiley +1 more source
Severe Toxicities From Definitive Chemoradiotherapy for Oropharyngeal Cancer in a Patient With Comorbid Sjögren's Syndrome. [PDF]
Ooishi M +3 more
europepmc +1 more source
ABSTRACT Objectives While there are plausible biological explanations for the association between oral health and head and neck cancers (HNC), existing studies have yielded conflicting results. A key concern is that these associations are influenced by mediators, unmeasured risk factors, and biases. To address this, a negative control exposure was used
P. K. Elango +5 more
wiley +1 more source
Trends of Adjuvant Radiation After TORS in Clinically Node Negative Oropharyngeal Cancer. [PDF]
Khan NS, Bollig CA.
europepmc +1 more source

